Central Trust Company’s Exelixis EXEL Stock Holding History
Bought
Maintained
Sold
Other funds holding EXEL
FCM
VPM
VCM
Central Trust Company's EXEL Position: Q1 2026 in Review
Central Trust Company reduced its Exelixis (EXEL) stake by 0.66% in Q1 2026, selling an estimated $86 and leaving 300 shares worth $12.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1104.
Central Trust Company first reported a position in EXEL in Q1 2019 and has held it in 16 quarters since. The position peaked at $109K in Q1 2021. 695 funds tracked by Wall St. Rank hold EXEL as of Q1 2026.
- Central Trust Company held 300 shares of Exelixis worth $12.9K as of Q1 2026.
- Central Trust Company sold 2 Exelixis shares in Q1 2026, an estimated $86.
- Exelixis made up ﹤0.01% of Central Trust Company's portfolio in Q1 2026, its #1104 holding.
- Central Trust Company first reported a position in Exelixis in Q1 2019 and has held it in 16 quarters since.
- Central Trust Company's Exelixis position peaked at $109K in Q1 2021.
- 695 funds tracked by Wall St. Rank held Exelixis as of Q1 2026.
Based on Central Trust Company's 13F filing for Q1 2026, filed 17 Apr 2026.